Come up with a name for your new list and we'll add to it:
Zucara Therapeutics raised a round of funding on February 08, 2018. Investors include
National Research Council Canada.
Zucara Therapeutics, a spin-off of The Centre for Drug Research and Development (CDRD) and MaRS Innovation (MI), is developing drug therapy to prevent hypoglycemia in people with diabetes. The company…